Seamless Integration Into Your Site WellSyncs technology seamlessly integrates into your existing website, enabling you to offer a full suite of GLP-1 services directly to your consumers
Over time, consistent therapy may support steady weight loss, improved energy, better metabolic balance, and long-term body composition changes when combined with healthy lifestyle habits
Fewer cravings, steadier energy, and smoother blood sugar after you eat
New Insights and Promising Therapies Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials Effects of GLP-1 on ovarian dysfunction in polycystic ovary syndrome: A protocol for systematic review and meta-analysis These weight loss injections work by mimicking a hormone that regulates appetite and food intake
Gallbladder In the SCALE-trial, high-dose liraglutide for the treatment of obesity was associated with an increased risk of gallbladder events compared to placebo (2.5% versus 1.0% of patients, respectively) (84)
Dosing must only follow the protocol of the specific authorised trial in which a participant is enrolled
